FDA DEVICE FACTS
Selux AST System; Model AST Gen 1.0
Selux Diagnostics, Inc.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
Intended Use: The Selux AST System is intended to be used for the automated quantitative or qualitative susceptibility testing for most clinically significant aerobic microorganisms. The Selux AST System does not provide organism identification. Indications for Use: The Selux Gram-Positive Panel is intended for use with the Selux AST System as an in vitro test to determine the susceptibility of isolated colonies of specific Staphylococcus species and Enterococcus species to specific antimicrobial agents when used as instructed. The Selux Gram-Positive Panel is a quantitative test for the following antimicrobial agents with the specific organisms identified below:
• A mpicillin: Enterococcus faecium, Enterococcus faecalis
• Clindamycin: Staphylococcus aureus, Staphylococcus epidermidis
• Ceftaroline: Staphylococcus aureus
• Daptomycin: Staphylococcus aureus, Enterococcus faecalis
• Delafloxacin: Staphylococcus aureus, Staphylococcus haemolyticus, Enterococcus faecalis
• Eravacycline: Staphylococcus aureus, Enterococcus faecalis
• Erythromycin: Staphylococcus aureus
• Linezolid: Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus haemolyticus, Enterococcus f aecium, Enterococcus faecalis
• Levofloxacin: Enterococcus faecium, Enterococcus faecalis, methicillin-susceptible Staphylococcus aureus
• Minocycline: Staphylococcus aureus
• Oxacillin: Staphylococcus aureus, Staphylococcus lugdunensis
• Penicillin: Enterococcus faecium, Enterococcus faecalis, Staphylococcus aureus
• Trimethoprim: Staphylococcus aureus, Coagulase-Negative Staphylococci (including S. capitus, S. h aemolyticus, S. saprophyticus, S. simulans)
• Vancomycin: Staphylococcus aureus, Coagulase-Negative Staphylococci (CoNS) (including S. capitus, S. cohnii,
S. e pidermidis, S. haemolyticus, S. hominis, S. intermedius group, S. lugdunensis, S. saprophyticus, S. schleiferi,
S. si mulans) Enterococcus faecium, Enterococcus faecalis The Selux Gram-Positive Panel is a qualitative test for the following antimicrobial agents with the specific target organisms identified below:
• Cefoxitin Screen to predict mecA-mediated oxacillin resistance: Staphylococcus aureus, Staphylococcus lugdunensis
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。